Endothelium-Derived Hyperpolarizing Factor in the Brain

HomeStrokeVol. 33, No. 3Endothelium-Derived Hyperpolarizing Factor in the Brain Free AccessEditorialPDF/EPUBAboutView PDFView EPUBSections ToolsAdd to favoritesDownload citationsTrack citationsPermissions ShareShare onFacebookTwitterLinked InMendeleyReddit Jump toFree AccessEditorialPDF/EPUBEndothelium-Derived Hyperpolarizing Factor in the BrainA New Regulator of Cerebral Blood Flow? Elke M. Golding, PhD, Sean P. Marrelli, PhD, Junping You, MD, PhD and Robert M. BryanJr, PhD Elke M. GoldingElke M. Golding From the Departments of Anesthesiology (E.M.G., S.P.M., J.P., R.M.B.), Molecular Physiology and Biophysics (R.M.B.), and Medicine (R.M.B.), Baylor College of Medicine, Houston, Texas. Search for more papers by this author , Sean P. MarrelliSean P. Marrelli From the Departments of Anesthesiology (E.M.G., S.P.M., J.P., R.M.B.), Molecular Physiology and Biophysics (R.M.B.), and Medicine (R.M.B.), Baylor College of Medicine, Houston, Texas. Search for more papers by this author , Junping YouJunping You From the Departments of Anesthesiology (E.M.G., S.P.M., J.P., R.M.B.), Molecular Physiology and Biophysics (R.M.B.), and Medicine (R.M.B.), Baylor College of Medicine, Houston, Texas. Search for more papers by this author and Robert M. BryanJrRobert M. BryanJr From the Departments of Anesthesiology (E.M.G., S.P.M., J.P., R.M.B.), Molecular Physiology and Biophysics (R.M.B.), and Medicine (R.M.B.), Baylor College of Medicine, Houston, Texas. Search for more papers by this author Originally published7 Apr 2018https://doi.org/10.1161/str.33.3.661Stroke. 2002;33:661–663EDHF DefinedIt is well established that stimulation of receptors on the endothelium can elicit dilation of arteries and arterioles by initiating the synthesis and release of nitric oxide (NO) and/or metabolites of the cyclooxygenase pathway (most often prostacyclin). Recent evidence now suggests that there is at least one other endothelium-dependent dilator mechanism that does not involve NO or a cyclooxygenase metabolite. This mechanism has been termed “endothelium-derived hyperpolarizing factor” (EDHF). (Note that EDHF is different from endothelium-derived relaxing factor [EDRF], which is often associated with NO. It should also be noted that recent studies suggest that EDHF may not be a “factor” but rather a process or mechanism. To be more accurate, the term “EDHF” should be referred to as a non-NO, noncyclooxygenase endothelium-dependent hyperpolarization. However, in order to maintain consistency in the literature, we will refer to it as “EDHF.”) We believe that EDHF is a major regulator of cerebral blood flow during physiological states and may become even more important following pathological insults such as ischemia or traumatic brain injury. The purpose of this editorial is to familiarize the reader with EDHF and to highlight the potential importance of EDHF in the cerebral circulation.While the defining criteria for EDHF or the mechanism of endothelium-dependent hyperpolarizations can vary, we will characterize the process as (1) requiring endothelium, (2) being distinct from NO and a cyclooxygenase metabolite, (3) hyperpolarizing the vascular smooth muscle (VSM), and (4) involving calcium-activated potassium (KCa) channels.EDHF in the PeripheryThe existence of a third pathway was alluded to in the late 1980s, when some endothelium-dependent relaxations were shown to be resistant to inhibitors of NO and cyclooxygenase.1,2 Although it has been suggested that EDHF-dependent dilations reflect incomplete inhibition of nitric oxide synthase (NOS),3 there is now convincing evidence of the existence of a non-NO, noncyclooxygenase pathway. In cerebral vessels, extensive studies with a combination of inhibitors4 and eNOS knockout mice5 demonstrate that a pathway independent from NO is involved. These relaxations were further characterized by hyperpolarization of the VSM and sensitivity to some inhibitors of KCa channels. The VSM hyperpolarization serves to close voltage-gated calcium channels, resulting in decreased concentrations of cytoplasmic Ca2+ and ultimately VSM relaxation (or dilation).Over the past 10 years, there has been much debate as to the mechanism associated with the EDHF-mediated dilations. The first idea involved epoxyeicosatrienoic acids (EETs), a product of arachidonic acid metabolism through the cytochrome P450 epoxygenase pathway.6–8 EETs, which are either stored in the endothelium or synthesized on demand, were proposed to diffuse to the VSM, open KCa channels, and hyperpolarize the VSM.9The second idea is that the potassium ion (K+) is EDHF.10 On stimulation of endothelial receptors, the K+ conductance of endothelial cells would increase by opening KCa channels. This would be followed by an efflux of K+ from endothelial cells as a result of the electrochemical gradient causing K+ to increase from 3 mmol/L to ≈12 mmol/L in the extracellular space between the endothelial and VSM cells.10 The increase in potassium would hyperpolarize the VSM by activating inwardly rectifying potassium channels and the Na+/K+ pump. As stated above, the hyperpolarization would then lead to dilation.A third line of studies implicate gap junctions that couple endothelial cells and VSM cells (myoendothelial gap junctions). These myoendothelial junctions would provide a conduit for either the EDHF or an electrical current to move between the endothelium and VSM.11 If the process involves only the movement of current, then “EDHF” would not be a factor per se but rather a process. Consequently, “endothelium-dependent hyperpolarization” might best describe the phenomenon.Additionally, there is evidence that hydrogen peroxide,12 anandamide,13 or products of the lipoxygenase pathway14,15 are involved with the EDHF dilations. Although these latter mediators have been less studied and, therefore, less scrutinized, they may be no less significant. In all likelihood, several EDHFs and/or EDHF-like processes exist and are dependent on the vascular bed, species, and physiological state. For more in-depth reviews of the EDHF mechanisms in peripheral vessels see the previous works by Feletou and Vanhoutte16 and McGuire et al.17EDHF in the BrainAlthough it was previously known that cerebrovascular smooth muscle could be hyperpolarized by endothelial mechanisms,18 it was not until 1995 that evidence began to emerge for the existence of EDHF in cerebral vessels. ATP, UTP, substance P, A23187 (Ca2+ ionophore), and acetylcholine have been reported to elicit dilations through the release of EDHF in addition to NO.4,19–29 Of significance, the EDHF response was shown to exist in human cerebral arteries.19 The dilator mechanism in these aforementioned studies fits the criteria for EDHF. That is, it required intact endothelium, it was not blocked by inhibitors of NO synthase or cyclooxygenase, it hyperpolarized the VSM by ≈15 mV, and it was blocked by inhibitors of KCa channels.Very little is known regarding the identity of EDHF or mechanism of action in cerebral vessels. Ca2+ does appear to be a second messenger in the pathway, with the amount of endothelial Ca2+ required to elicit an EDHF-mediated dilation being approximately 100 nmol/L greater than that required to elicit a purely NO-mediated dilation (340 nmol/L versus 220 nmol/L, respectively).30 Most significantly, the EDHF response in cerebral vessels appears to be distinctly unique; that is, the identity and/or process of EDHF in cerebral vessels is likely different from that in peripheral vessels. This is illustrated by the work of Dong and coworkers, who reported that while clotrimazole attenuated EDHF-mediated responses in the guinea pig cerebral artery, it had no effect on the mesenteric artery.27 Furthermore, while studies in the periphery have demonstrated that basal levels of NO inhibit EDHF,31 this was not shown to be the case in cerebral arteries.32 Therefore, the EDHF mechanism cannot be directly extrapolated from the mechanism in peripheral vessels, and it is imperative that EDHF is identified in cerebral vessels independently of peripheral vessels.The significance of EDHF in the brain is reflected in 3 recent observations:(1) The Relative Contribution of EDHF Increases as Vessel Caliber DecreasesThe EDHF response elicited by the luminal application of ATP has been shown to play a more prominent role in third- and fourth-order branches of the middle cerebral artery and penetrating arterioles than in middle cerebral arteries.25,26 This was in direct contrast to NO, which showed a diminishing role along the cerebrovascular tree.25 These findings suggest that with respect to purine and pyrimidine nucleotide stimulation, EDHF may be the predominant dilator mechanism in the regulation of smaller resistance arteries and arterioles. Due to the fundamental role of these smaller vessels in the control of vascular resistance, it would therefore appear that EDHF plays an important role in the regulation of vascular resistance and thus, in the control of cerebral blood flow during normal physiological states.(2) EDHF Is Upregulated Following Pathological ConditionsA potentiation of the EDHF response has been observed following ischemia reperfusion injury23,28 and traumatic brain injury.26,33 The EDHF component of the ATP dilation was shown to be enhanced in pial arterioles at 24 hours but not 1 hour following mild traumatic brain injury.33 Interestingly, the upregulation of EDHF following ischemia/reperfusion more than compensated for a suppressed response to NO that also occurred.23 While there is still much to be learned about the upregulation of EDHF following these pathological conditions, we presently speculate that it is a protective mechanism that helps to preserve endothelial-dependent relaxation of the injured cerebral arteries. Of note, we do not know if the upregulated response is the same or a different “EDHF” response to that occurring during nonpathological states.(3) EDHF Is Downregulated by EstrogenUnlike vessels isolated from male rats, the response to ATP in female middle cerebral arteries showed a negligible EDHF component of the dilation.34 Moreover, the contributing factor was estrogen, since EDHF-mediated dilations showed major enhancement in vessels isolated from ovariectomized females, and this upregulated EDHF response was again lost following estrogen replacement. This same effect of estrogen on the EDHF response was demonstrated in vivo using the pial window technique.35 Interestingly, the effects of estrogen on the EDHF response in cerebral vessels are just the opposite of those reported in peripheral vessels. Estrogen upregulates the EDHF response in peripheral vessels.36 Again, the response to estrogen provides more evidence that the EDHF response in cerebral vessels is unique. The implications of estrogen’s effect on EDHF in brain have yet to be determined, particularly in light of the fact that estrogen has displayed a protective influence following stroke.37,38Does EDHF Play a Role In Vivo?Most studies of EDHF to date have been carried out on isolated vessels. Measurement of VSM hyperpolarization, one of the criteria defining EDHF, cannot be measured practically in cerebral arteries and arterioles in vivo. Nevertheless, dilations in pial vessels in vivo that are resistant to inhibitors of NO synthase and cyclooxygenase have been observed,5,35 and these dilations fit the criteria for EDHF with the exception of VSM hyperpolarization. Whether these dilations involve the EDHF response or not is irrelevant, because the observations would still represent a third endothelium-dependent mechanism of dilation in cerebral vessels. Notwithstanding the technical limitations, evidence is emerging that the EDHF response or a similar response does exist in vivo.5,35What Does the Future Hold?The discovery of a new endothelial-mediated dilatory process is intriguing, but many questions must be answered before EDHF can be considered a bona fide regulator of cerebral blood flow. For example, what is its physiological role? When is it functional? Does it play a role in vivo during pathological states? Presently, EDHF is primarily studied following inhibition of both NO and the cyclooxygenase pathway. Only when the mechanism of EDHF-mediated dilations is elucidated can it be studied in the presence of NO and cyclooxygenase, and only then can its relative importance in cerebral vessels during normal physiological conditions be determined. Furthermore, interpretation of these mechanisms is complicated by the fact that KCa channel inhibitors can inhibit both NO and EDHF. Nevertheless, we believe that the existing studies are provocative and indicate the necessity for further investigations involving EDHF in the brain. If EDHF does indeed prove to be protective following pathological conditions, as we speculate, then it must be considered as a therapeutic strategy to be used in the clinical treatment of brain injury. The challenge for the future lies not only in the characterization of EDHF but also in its role in regulating cerebral blood flow.The opinions expressed in this editorial are not necessarily those of the editors or of the American Stroke Association.The experimental work reported herein was supported by the National Institute of Neurological Disorders and Stroke grants NS-27616 and NS-37250 (Bryan) and the National American Heart Association Scientist Development grant 0130250N (Golding). The authors acknowledge the contribution from the others members of our laboratory: Marie L. Steenberg, Dr T. David Johnson, Dr Lisa A. Schildmeyer, and Dorota M. Ferens.FootnotesCorrespondence to Elke M. Golding, PhD, Department of Anesthesiology, Baylor College of Medicine, One Baylor Plaza, Suite 434D, Houston, TX 77030. E-mail [email protected] References 1 Chen G, Suzuki H, Weston AH. Acetylcholine releases endothelium-derived hyperpolarizing factor and EDRF from rat blood vessels. Br J Pharmacol. 1988; 95: 1165–1174.CrossrefMedlineGoogle Scholar2 Feletou M, Vanhoutte PM. Endothelium-dependent hyperpolarization of canine coronary smooth muscle. Br J Pharmacol. 1988; 93: 515–524.CrossrefMedlineGoogle Scholar3 Cohen RA, Plane F, Najibi S, Huk I, Malinski T, Garland CJ. Nitric oxide is the mediator of both endothelium-dependent relaxation and hyperpolarization of the rabbit carotid artery. Proc Natl Acad Sci U S A. 1997; 94: 4193–4198.CrossrefMedlineGoogle Scholar4 You J, Johnson TD, Marrelli SP, Mombouli JV, Bryan RM Jr. P2 u receptor-mediated release of endothelium-derived relaxing factor/nitric oxide and endothelium-derived hyperpolarizing factor from cerebrovascular endothelium in rats. Stroke. 1999; 30: 1125–1133.CrossrefMedlineGoogle Scholar5 Faraci FM, Heistad DD, Lamping KG. ADP-induced dilatation of cerebral arterioles is mediated by EDHF: evidence from wild-type and eNOS-deficient mice.FASEB J. In press.Google Scholar6 Bolz SS, Fisslthaler B, Pieperhoff S, De Wit C, Fleming I, Busse R, Pohl U. Antisense oligonucleotides against cytochrome P450 2C8 attenuate EDHF-mediated Ca(2+) changes and dilation in isolated resistance arteries. FASEB J. 2000; 14: 255–260.CrossrefMedlineGoogle Scholar7 Campbell WB, Gebremedhin D, Pratt PF, Harder DR. Identification of epoxyeicosatrienoic acids as endothelium-derived hyperpolarizing factors. Circ Res. 1996; 78: 415–423.CrossrefMedlineGoogle Scholar8 Fisslthaler B, Popp R, Kiss L, Potente M, Harder DR, Fleming I, Busse R. Cytochrome P450 2C is an EDHF synthase in coronary arteries. Nature. 1999; 401: 493–497.CrossrefMedlineGoogle Scholar9 Hecker M, Bara AT, Bauersachs J, Busse R. Characterization of endothelium-derived hyperpolarizing factor as a cytochrome P450-derived arachidonic acid metabolite in mammals. J Physiol. 1994; 481: 407–414.CrossrefMedlineGoogle Scholar10 Edwards G, Dora KA, Gardener MJ, Garland CJ, Weston AH. K+ is an endothelium-derived hyperpolarizing factor in rat arteries. Nature. 1998; 396: 269–272.CrossrefMedlineGoogle Scholar11 Chaytor AT, Evans WH, Griffith TM. Central role of heterocellular gap junctional communication in endothelium-dependent relaxations of rabbit arteries. J Physiol. 1998; 508: 561–573.CrossrefMedlineGoogle Scholar12 Matoba T, Shimokawa H, Nakashima M, Hirakawa Y, Mukai Y, Hirano K, Kanaide H, Takeshita A. Hydrogen peroxide is an endothelium-derived hyperpolarizing factor in mice. J Clin Invest. 2000; 106: 1521–1530.CrossrefMedlineGoogle Scholar13 Randall MD, Alexander SP, Bennett T, Boyd EA, Fry JR, Gardiner SM, Kemp PA, McCulloch AI, Kendall DA. An endogenous cannabinoid as an endothelium-derived vasorelaxant. Biochem Biophys Res Commun. 1996; 229: 114–120.CrossrefMedlineGoogle Scholar14 Pfister SL, Spitzbath N, Nithipatakom K, Edgemond WS, Falck WR, Campbell WB. Identification of the 11,14,15- and 11,12,15-trihydroxyeicosatrienoic acids as endothelium-derived relaxing factors of rabbit aorta. J Biol Chem. 1998; 273: 30879–30887.CrossrefMedlineGoogle Scholar15 Zink MH, Oltman CL, Lu T, Katakam PV, Kaduce TL, Lee H, Dellsperger KC, Spector AA, Myers PR, Weintraub NL. 12-lipoxygenase in porcine coronary microcirculation: implications for coronary vasoregulation. Am J Physiol Heart Circ Physiol. 2001; 280: H693–H704.CrossrefMedlineGoogle Scholar16 Feletou M, Vanhoutte PM. Endothelium-dependent hyperpolarization of vascular smooth muscle cells. Acta Pharmacol Sin. 2000; 21: 1–18.MedlineGoogle Scholar17 McGuire JJ, Ding H, Triggle CR. Endothelium-derived relaxing factors: a focus on endothelium-derived hyperpolarizing factor(s). Can J Physiol Pharmacol. 2001; 79: 443–470.CrossrefMedlineGoogle Scholar18 Brayden JE, Wellman GC. Endothelium-dependent dilation of feline cerebral arteries: role of membrane potential and cyclic nucleotides. J Cereb Blood Flow Metab. 1989; 9: 256–263.CrossrefMedlineGoogle Scholar19 Petersson J, Zygmunt PM, Brandt L, Hogestatt ED. Substance P-induced relaxation and hyperpolarization in human cerebral arteries. Br J Pharmacol. 1995; 115: 889–894.CrossrefMedlineGoogle Scholar20 Petersson J, Zygmunt PM, Hogestatt ED. Characterization of the potassium channels involved in EDHF-mediated relaxation in cerebral arteries. Br J Pharmacol. 1997; 120: 1344–1350.CrossrefMedlineGoogle Scholar21 Petersson J, Zygmunt PM, Jonsson P, Hogestatt ED. Characterization of endothelium-dependent relaxation in guinea pig basilar artery: effect of hypoxia and role of cytochrome P450 mono-oxygenase. J Vasc Res. 1998; 35: 285–294.CrossrefMedlineGoogle Scholar22 Yamakawa N, Ohhashi M, Waga S, Itoh T. Role of endothelium in regulation of smooth muscle membrane potential and tone in the rabbit middle cerebral artery. Br J Pharmacol. 1997; 121: 1315–1322.CrossrefMedlineGoogle Scholar23 Marrelli SP, Khorovets A, Johnson TD, Childres WF, Bryan RM Jr. P2 purinoceptor-mediated dilations in the rat middle cerebral artery after ischemia-reperfusion. Am J Physiol. 1999; 276: H33–H41.MedlineGoogle Scholar24 Triggle CR, Dong H, Waldron GJ, Cole WC. Endothelium-derived hyperpolarizing factor(s): species and tissue heterogeneity. Clin Exp Pharmacol Physiol. 1999; 26: 176–179.CrossrefMedlineGoogle Scholar25 You J, Johnson TD, Marrelli SP, Bryan RM Jr. Functional heterogeneity of endothelial P2 purinoceptors in the cerebrovascular tree of the rat. Am J Physiol. 1999; 277: H893–H900.MedlineGoogle Scholar26 Bryan RM Jr, You J, Marrelli SP, Golding EM. Endothelium-derived hyperpolarizing factor in the brain: fact or fiction? In: Proceedings of the 7th World Congress for Microcirculation. Sydney, Australia, August 19–22, 2001. Bologna, Italy: Monduzzi Editore; 2001.Google Scholar27 Dong H, Jiang Y, Cole WC, Triggle CR. Comparison of the pharmacological properties of EDHF-mediated vasorelaxation in guinea-pig cerebral and mesenteric resistance vessels. Br J Pharmacol. 2000; 130: 1983–1991.CrossrefMedlineGoogle Scholar28 Marrelli SP, Childres WF, Goddard-Finegold J, Bryan RM Jr. Potentiated EDHF-mediated dilations in the rat middle cerebral artery following ischemia/reperfusion.In: Vanhoutte PM, ed. EDHF 3 Proceedings. Amsterdam: Harwood Academic Publishers; 2001.Google Scholar29 Zygmunt PM, Sorgard M, Petersson J, Johansson R, Hogestatt ED. Differential actions of anandamide, potassium ions and endothelium-derived hyperpolarizing factor in guinea-pig basilar artery. Naunyn Schmiedebergs Arch Pharmacol. 2000; 361: 535–542.CrossrefMedlineGoogle Scholar30 Marrelli SP. Mechanisms of endothelial P2Y(1)- and P2Y(2)-mediated vasodilatation involve differential [Ca2+]i responses. Am J Physiol Heart Circ Physiol. 2001; 281: H1759–H1766.CrossrefMedlineGoogle Scholar31 Nishikawa Y, Stepp DW, Chilian WM. Nitric oxide exerts feedback inhibition on EDHF-induced coronary arteriolar dilation in vivo. Am J Physiol Heart Circ Physiol. 2000; 279: H459–H465.CrossrefMedlineGoogle Scholar32 Schildmeyer LA, Bryan RM Jr. Effect of NO on the EDHF response in rat middle cerebral arteries. Am J Physiol Heart Circ Physiol. 2002; 282: H734–H738.CrossrefMedlineGoogle Scholar33 Golding EM, You J, Robertson CS, Bryan RM Jr. Potentiated endothelium-derived hyperpolarizing factor-mediated dilations in cerebral arteries following mild head injury. J Neurotrauma. 2001; 18: 691–697.CrossrefMedlineGoogle Scholar34 Golding EM, Kepler TE. Role of estrogen in modulating EDHF-mediated dilations in the female rat middle cerebral artery. Am J Physiol Heart Circ Physiol. 2001; 280: H2417–H2423.CrossrefMedlineGoogle Scholar35 Xu HL, Santizo RA, Koenig HM, Pelligrino DA. Chronic estrogen depletion alters adenosine diphosphate-induced pial arteriolar dilation in female rats. Am J Physiol Heart Circ Physiol. 2001; 281: H2105–H2112.CrossrefMedlineGoogle Scholar36 McCulloch AI, Randall MD. Sex differences in the relative contributions of nitric oxide and EDHF to agonist-stimulated endothelium-dependent relaxations in the rat isolated mesenteric arterial bed. Br J Pharmacol. 1998; 123: 1700–1706.CrossrefMedlineGoogle Scholar37 Hurn PD, Macrae IM. Estrogen as a neuroprotectant in stroke. J Cereb Blood Flow Metab. 2000; 20: 631–652.CrossrefMedlineGoogle Scholar38 Wang Q, Santizo R, Baughman VL, Pelligrino DA. Estrogen provides neuroprotection in transient forebrain ischemia through perfusion-independent mechanisms in rats. Stroke. 1999; 30: 630–637.CrossrefMedlineGoogle Scholar Previous Back to top Next FiguresReferencesRelatedDetailsCited By Shi X, Li P, Liu H and Prokosch V (2022) Oxidative Stress, Vascular Endothelium, and the Pathology of Neurodegeneration in Retina, Antioxidants, 10.3390/antiox11030543, 11:3, (543) Hansen F, Esteves G, Mogensen S, Prat-Duran J, Secher N, Løfgren B, Granfeldt A and Simonsen U (2021) Increased cerebral endothelium-dependent vasodilation in rats in the postcardiac arrest period, Journal of Applied Physiology, 10.1152/japplphysiol.00373.2021, 131:4, (1311-1327), Online publication date: 1-Oct-2021. Ahmad A, Patel V, Xiao J and Khan M (2020) The Role of Neurovascular System in Neurodegenerative Diseases, Molecular Neurobiology, 10.1007/s12035-020-02023-z, 57:11, (4373-4393), Online publication date: 1-Nov-2020. Kermorgant M, Nasr N, Czosnyka M, Arvanitis D, Hélissen O, Senard J and Pavy-Le Traon A (2020) Impacts of Microgravity Analogs to Spaceflight on Cerebral Autoregulation, Frontiers in Physiology, 10.3389/fphys.2020.00778, 11 Matiasek K, Matiasek L and Rosati M (2020) Hypertension and the Central Nervous System Hypertension in the Dog and Cat, 10.1007/978-3-030-33020-0_10, (241-264), . Gao Z, Cilento E, Stewart T and Zhang J (2020) Vascular Dysfunction and Neurodegenerative Disease Vessel Based Imaging Techniques, 10.1007/978-3-030-25249-6_1, (3-16), . Guo Z, Jin H, Sun X, Tong L, Zhang J and Yang Y (2019) Cerebral Venous Regulation Cerebral Venous System in Acute and Chronic Brain Injuries, 10.1007/978-3-319-96053-1_4, (87-101), . Duschek S, Hoffmann A, Bair A, Reyes del Paso G and Montoro C (2018) Cerebral blood flow modulations during proactive control in chronic hypotension, Brain and Cognition, 10.1016/j.bandc.2018.06.008, 125, (135-141), Online publication date: 1-Aug-2018. Li Y, Lapina N, Weinzierl N, Schilling L and Karamyan V (2018) Enhancement of bradykinin-induced relaxation by focal brain ischemia in the rat middle cerebral artery: Receptor expression upregulation and activation of multiple pathways, PLOS ONE, 10.1371/journal.pone.0198553, 13:6, (e0198553) Chen S, Zhang J, Hu Y, Hu D, Gao S, Fan Y, Wang Y, Jiao Y and Chen Z (2018) Total Flavones of Rhododendron simsii Planch Flower Protect against Cerebral Ischemia-Reperfusion Injury via the Mechanism of Cystathionine- γ -Lyase-Produced H 2 S , Evidence-Based Complementary and Alternative Medicine, 10.1155/2018/8903849, 2018, (1-11), Online publication date: 31-May-2018. Guerra G, Lucariello A, Perna A, Botta L, De Luca A and Moccia F (2018) The Role of Endothelial Ca2+ Signaling in Neurovascular Coupling: A View from the Lumen, International Journal of Molecular Sciences, 10.3390/ijms19040938, 19:4, (938) Rivera-Lara L, Zorrilla-Vaca A, Geocadin R, Healy R, Ziai W and Mirski M (2017) Cerebral Autoregulation-oriented Therapy at the Bedside, Anesthesiology, 10.1097/ALN.0000000000001625, 126:6, (1187-1199), Online publication date: 1-Jun-2017. Onetti Y, Dantas A, Pérez B, McNeish A, Vila E and Jiménez-Altayó F (2016) Peroxynitrite formed during a transient episode of brain ischaemia increases endothelium-derived hyperpolarization-type dilations in thromboxane/prostaglandin receptor-stimulated rat cerebral arteries, Acta Physiologica, 10.1111/apha.12809, 220:1, (150-166), Online publication date: 1-May-2017. Matin N, Pires P, Garver H, Jackson W and Dorrance A (2016) DOCA-salt hypertension impairs artery function in rat middle cerebral artery and parenchymal arterioles, Microcirculation, 10.1111/micc.12308, 23:7, (571-579), Online publication date: 1-Oct-2016. Chillon J and Thorin E (2016) Arterial Stiffness and the Brain Hypertension and the Brain as an End-Organ Target, 10.1007/978-3-319-25616-0_7, (135-153), . Hill-Eubanks D, Gonzales A, Sonkusare S and Nelson M (2014) Vascular TRP Channels: Performing Under Pressure and Going with the Flow, Physiology, 10.1152/physiol.00009.2014, 29:5, (343-360), Online publication date: 1-Sep-2014. Bolduc V, Thorin-Trescases N and Thorin E (2013) Endothelium-dependent control of cerebrovascular functions through age: exercise for healthy cerebrovascular aging, American Journal of Physiology-Heart and Circulatory Physiology, 10.1152/ajpheart.00624.2012, 305:5, (H620-H633), Online publication date: 1-Sep-2013. Crossland R, Durgan D, Lloyd E, Phillips S, Reddy A, Marrelli S and Bryan R (2013) A new rodent model for obstructive sleep apnea: effects on ATP-mediated dilations in cerebral arteries, American Journal of Physiology-Regulatory, Integrative and Comparative Physiology, 10.1152/ajpregu.00244.2013, 305:4, (R334-R342), Online publication date: 15-Aug-2013. Gonzales R (2013) Androgens and the cerebrovasculature: modulation of vascular function during normal and pathophysiological conditions, Pflügers Archiv - European Journal of Physiology, 10.1007/s00424-013-1267-3, 465:5, (627-642), Online publication date: 1-May-2013. Han J, Chen Z and He G (2013) Acetylcholine- and Sodium Hydrosulfide^|^ndash;Induced Endothelium-Dependent Relaxation and Hyperpolarization in Cerebral Vessels of Global Cerebral Ischemia^|^ndash;Reperfusion Rat, Journal of Pharmacological Sciences, 10.1254/jphs.12277FP, 121:4, (318-326), . Regoli D, Plante G and Gobeil F (2012) Impact of kinins in the treatment of cardiovascular diseases, Pharmacology & Therapeutics, 10.1016/j.pharmthera.2012.04.002, 135:1, (94-111), Online publication date: 1-Jul-2012. TAJBAKHSH N and SOKOYA E (2012) Regulation of Cerebral Vascular Function by Sirtuin 1, Microcirculation, 10.1111/j.1549-8719.2012.00167.x, 19:4, (336-342), Online publication date: 1-May-2012. Fan Y, Chen Z, Guo Y, Wang Q and Song B (2011) Cellular mechanisms underlying Hyperin-induced relaxation of rat basilar artery, Fitoterapia, 10.1016/j.fitote.2011.01.023, 82:4, (626-631), Online publication date: 1-Jun-2011. Peterson E, Wang Z and Britz G (2011) Regulation of Cerebral Blood Flow, International Journal of Vascular Medicine, 10.1155/2011/823525, 2011, (1-8), . Tan C, Khurana V, Benarroch E and Meyer F (2011) Cerebral Blood Flow and Metabolism and Cerebral Ischemia Youmans Neurological Surgery, 10.1016/B978-1-4160-5316-3.00346-4, (3537-3562), . Atochin D, Yuzawa I, Li Q, Rauwerdink K, Malhotra R, Chang J, Brouckaert P, Ayata C, Moskowitz M, Bloch K, Huang P and Buys E (2010) Soluble Guanylate Cyclase α1β1 Limits Stroke Size and Attenuates Neurological Injury, Stroke, 41:8, (1815-1819), Online publication date: 1-Aug-2010. Ainslie P and Duffin J (2009) Integration of cerebrovascular CO 2 reactivity and chemoreflex control of breathing: mechanisms of regulation, measurement, and interpretation , American Journal of Physiology-Regulatory, Integrative and Comparative Physiology, 10.1152/ajpregu.91008.2008, 296:5, (R1473-R1495), Online publication date: 1-May-2009. Tuma R (2008) The Cerebral Microcirculation Comprehensive Physiology, 10.1002/cphy.cp020411, (485-520), Online publication date: 1-Dec-2008. Bellien J, Thuillez C and Joannides R (2008) Contribution of endothelium-derived hyperpolarizing factors to the regulation of vascular tone in humans, Fundamental & Clinical Pharmacology, 10.1111/j.1472-8206.2008.00610.x, 22:4, (363-377), Online publication date: 1-Aug-2008. Watanabe Y, Kusama N and Itoh T (2009) Effects of chronic in vivo administration of nitroglycerine on ACh-induced endothelium-dependent relaxation in rabbit cerebral arteries , British Journal of Pharmacology, 10.1038/sj.bjp.0707562, 153:1, (132-139), Online publication date: 1-Jan-2008. Tuma R (2008) The Cerebral Microcirculation Microcirculation, 10.1016/B978-0-12-374530-9.00013-9, (485-520), . Jiménez-Altayó F, Martín A, Rojas S, Justicia C, Briones A, Giraldo J, Planas A and Vila E (2007) Transient middle cerebral artery occlusion causes different structural, mechanical, and myogenic alterations in normotensive and hypertensive rats, American Journal of Physiology-Heart and Circulatory Physiology, 10.1152/ajpheart.00165.2007, 293:1, (H628-H635), Online publication date: 1-Jul-2007. Franco Folino A (2007) Cerebral Autoregulation and Syncope, Progress in Cardiovascular Diseases, 10.1016/j.pcad.2007.01.001, 50:1, (49-80), Online publication date: 1-Jul-2007. Sokoya E, Burns A, Marrelli S and Chen J (2007) Myoendothelial gap junction frequency does not account for sex differences in EDHF responses in rat MCA, Microvascular Research, 10.1016/j.mvr.2007.03.003, 74:1, (39-44), Online publication date: 1-Jul-2007. Prisby R, Wilkerson M, Sokoya E, Bryan R, Wilson E and Delp M (2006) Endothelium-dependent vasodilation of cerebral arteries is altered with simulated microgravity through nitric oxide synthase and EDHF mechanisms, Journal of Applied Physiology, 10.1152/japplphysiol.00941.2005, 101:1, (348-353), Online publication date: 1-Jul-2006. Andresen J, Shafi N and Bryan R (2006) Endothelial influences on cerebrovascular tone, Journal of Applied Physiology, 10.1152/japplphysiol.00937.2005, 100:1, (318-327), Online publication date: 1-Jan-2006. You J, Golding E and Bryan R (2005) Arachidonic acid metabolites, hydrogen peroxide, and EDHF in cerebral arteries, American Journal of Physiology-Heart and Circulatory Physiology, 10.1152/ajpheart.01046.2004, 289:3, (H1077-H1083), Online publication date: 1-Sep-2005. McNeish A, Dora K and Garland C (2005) Possible Role for K+ in Endothelium-Derived Hyperpolarizing Factor–Linked Dilatation in Rat Middle Cerebral Artery, Stroke, 36:7, (1526-1532), Online publication date: 1-Jul-2005. Banaji M, Tachtsidis I, Delpy D and Baigent S (2005) A physiological model of cerebral blood flow control, Mathematical Biosciences, 10.1016/j.mbs.2004.10.005, 194:2, (125-173), Online publication date: 1-Apr-2005. Faraci F, Lynch C and Lamping K (2004) Responses of cerebral arterioles to ADP: eNOS-dependent and eNOS-independent mechanisms, American Journal of Physiology-Heart and Circulatory Physiology, 10.1152/ajpheart.00392.2004, 287:6, (H2871-H2876), Online publication date: 1-Dec-2004. Cipolla M, Vitullo L and McKinnon J (2004) Cerebral artery reactivity changes during pregnancy and the postpartum period: a role in eclampsia?, American Journal of Physiology-Heart and Circulatory Physiology, 10.1152/ajpheart.01154.2003, 286:6, (H2127-H2132), Online publication date: 1-Jun-2004. Iadecola C (2004) Neurovascular regulation in the normal brain and in Alzheimer's disease, Nature Reviews Neuroscience, 10.1038/nrn1387, 5:5, (347-360), Online publication date: 1-May-2004. Gonzales R, Krause D and Duckles S (2004) Testosterone suppresses endothelium-dependent dilation of rat middle cerebral arteries, American Journal of Physiology-Heart and Circulatory Physiology, 10.1152/ajpheart.00663.2003, 286:2, (H552-H560), Online publication date: 1-Feb-2004. Rosenblum W (2003) ATP-Sensitive Potassium Channels in the Cerebral Circulation, Stroke, 34:6, (1547-1552), Online publication date: 1-Jun-2003.Golding E, Ferens D and Marrelli S (2002) Altered Calcium Dynamics Do Not Account for Attenuation of Endothelium-Derived Hyperpolarizing Factor–Mediated Dilations in the Female Middle Cerebral Artery, Stroke, 33:12, (2972-2977), Online publication date: 1-Dec-2002. You J, Marrelli S and Bryan R (2016) Role of Cytoplasmic Phospholipase A 2 in Endothelium-Derived Hyperpolarizing Factor Dilations of Rat Middle Cerebral Arteries , Journal of Cerebral Blood Flow & Metabolism, 10.1097/01.WCB.0000037996.34930.2E, 22:10, (1239-1247), Online publication date: 1-Oct-2002. Marrelli S (2002) Altered Endothelial Ca2+ Regulation After Ischemia/Reperfusion Produces Potentiated Endothelium-Derived Hyperpolarizing Factor–Mediated Dilations, Stroke, 33:9, (2285-2291), Online publication date: 1-Sep-2002. March 2002Vol 33, Issue 3 Advertisement Article InformationMetrics https://doi.org/10.1161/str.33.3.661PMID: 11872883 Originally publishedApril 7, 2018 Keywordsbrainblood vesselsvasodilationendotheliumPDF download Advertisement